JP2001503265A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001503265A5 JP2001503265A5 JP1998520525A JP52052598A JP2001503265A5 JP 2001503265 A5 JP2001503265 A5 JP 2001503265A5 JP 1998520525 A JP1998520525 A JP 1998520525A JP 52052598 A JP52052598 A JP 52052598A JP 2001503265 A5 JP2001503265 A5 JP 2001503265A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3009496P | 1996-10-25 | 1996-10-25 | |
| US60/030,094 | 1996-10-25 | ||
| PCT/US1997/018700 WO1998018923A1 (en) | 1996-10-25 | 1997-10-23 | NOVEL flt-3 RECEPTOR AGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001503265A JP2001503265A (ja) | 2001-03-13 |
| JP2001503265A5 true JP2001503265A5 (enExample) | 2005-06-16 |
Family
ID=21852464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52052598A Abandoned JP2001503265A (ja) | 1996-10-25 | 1997-10-23 | 新規なｆｌｔ３受容体アゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6660257B1 (enExample) |
| EP (1) | EP0950099A1 (enExample) |
| JP (1) | JP2001503265A (enExample) |
| AU (1) | AU733964B2 (enExample) |
| BR (1) | BR9714355A (enExample) |
| CA (1) | CA2268027A1 (enExample) |
| WO (1) | WO1998018923A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
| US6291661B1 (en) | 1998-07-02 | 2001-09-18 | Immunex Corporation | flt3-L mutants and method of use |
| JP2003523398A (ja) * | 2000-02-24 | 2003-08-05 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 樹状細胞のインビボ活性化によるアジュバント治療 |
| WO2002100317A2 (en) | 2001-05-25 | 2002-12-19 | The Trustees Of The University Of Pennsylvania | Targeted particles and methods of using the same |
| EP1425304B9 (en) | 2001-07-11 | 2010-09-08 | Maxygen, Inc. | G-csf conjugates |
| EP1668114B1 (en) * | 2003-08-18 | 2009-11-04 | The Regents of the University of California | Polypeptide display libraries and methods of making and using thereof |
| US7506180B2 (en) * | 2005-03-10 | 2009-03-17 | Hewlett-Packard Development Company, L.P. | System and method for determining the power drawn from a switching power supply by counting the number of times a switching power supply switch is enabled |
| US7756681B2 (en) | 2005-03-10 | 2010-07-13 | Hewlett-Packard Development Company, L.P. | Power supply circuit |
| KR20080027291A (ko) | 2005-06-01 | 2008-03-26 | 맥시겐 홀딩스 엘티디 | 피이지화된 지-씨에스에프 폴리펩타이드 및 그 제조방법 |
| AU2006284651C1 (en) | 2005-08-31 | 2013-09-12 | The Regents Of The University Of California | Cellular libraries of peptide sequences (CLiPS) and methods of using the same |
| US8293685B2 (en) | 2007-07-26 | 2012-10-23 | The Regents Of The University Of California | Methods for enhancing bacterial cell display of proteins and peptides |
| US8921516B2 (en) * | 2010-12-08 | 2014-12-30 | Corning Incorporated | Synthetic, defined fibronectin mimetic peptides and surfaces modified with the same |
| US10611837B2 (en) | 2014-04-10 | 2020-04-07 | Seattle Children's Hospital | Transgene genetic tags and methods of use |
| AU2016306209B2 (en) | 2015-08-07 | 2023-07-06 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Bispecific CAR T-cells for solid tumor targeting |
| CA3048648A1 (en) | 2017-01-10 | 2018-07-19 | The General Hospital Corporation | T cells expressing a chimeric antigen receptor |
| JP7566628B2 (ja) * | 2018-01-10 | 2024-10-15 | ザ ジェネラル ホスピタル コーポレイション | キメラ抗原受容体を発現する免疫細胞 |
| SG11202104352XA (en) * | 2018-12-18 | 2021-05-28 | Boehringer Ingelheim Io Canada Inc | Flt3 agonist antibodies and uses thereof |
| WO2020198659A1 (en) * | 2019-03-28 | 2020-10-01 | Orionis Biosciences, Inc. | Fms-like tyrosine kinase 3 ligand (flt3l)-based chimeric proteins |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2150495T5 (es) | 1993-05-19 | 2007-02-16 | Schering Corporation | Ligandos de flt3 purificados de mamifero y agonistas y antagonistas de los mismos. |
| US5554512A (en) | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
| CZ307995A3 (en) | 1993-05-24 | 1996-10-16 | Immunex Corp | Ligands for flt3 receptors |
| ATE273383T1 (de) | 1994-03-07 | 2004-08-15 | Immunex Corp | Ausrüstung für die extrakorporale zellkultur und zelltransplantation |
| US5635599A (en) | 1994-04-08 | 1997-06-03 | The United States Of America As Represented By The Department Of Health And Human Services | Fusion proteins comprising circularly permuted ligands |
| IL123832A0 (en) * | 1995-10-05 | 1998-10-30 | Searle & Co | Multi-functional hematopoietic receptor antagonists |
-
1997
- 1997-10-21 US US08/955,090 patent/US6660257B1/en not_active Expired - Fee Related
- 1997-10-23 BR BR9714355-3A patent/BR9714355A/pt not_active Application Discontinuation
- 1997-10-23 AU AU49853/97A patent/AU733964B2/en not_active Ceased
- 1997-10-23 CA CA002268027A patent/CA2268027A1/en not_active Abandoned
- 1997-10-23 EP EP97912746A patent/EP0950099A1/en not_active Ceased
- 1997-10-23 JP JP52052598A patent/JP2001503265A/ja not_active Abandoned
- 1997-10-23 WO PCT/US1997/018700 patent/WO1998018923A1/en not_active Ceased
-
2003
- 2003-08-20 US US10/644,355 patent/US20040127410A1/en not_active Abandoned